Assembly Biosciences, Inc. (NASDAQ: ASMB) reported Q2 EPS of ($0.32), $0.04 worse than the analyst estimate of ($0.28).

For earnings history and earnings-related data on Assembly Biosciences, Inc. (ASMB) click here.